Skip to content

DEERFIELD MANAGEMENT COMPANY, L.P.

Follow

13F filer, CIK 1009258, New York, NY

DEERFIELD MANAGEMENT COMPANY, L.P. reported $6,465,822,053 across 77 holdings for the quarter ended 2026-09-30, in a 13F-HR filed 2026-11-16. Its ten largest share positions make up 43.8% of the portfolio.

Accepted , ingested 13F-HR 0001213900-26-120609

Period
2026-09-30
Reported value
$6.47B
Holdings
77
Top 10 weight
43.8%
New
8
Sold out
13

Part of the filer group DEERFIELD MANAGEMENT COMPANY, L.P.

  • Deerfield UGP, LLC
  • Deerfield Mgmt, L.P.
  • Deerfield Mgmt V, L.P.
  • Deerfield Partners, L.P.
  • Deerfield Private Design Fund V, L.P.
  • Flynn James E
How groups are built

Stakes and trades reported after 2026-09-30

13D, 13G and Form 4 filings by this filer's group, dated after the 13F period, on securities the quarter does not hold as shares.

  • CLYM CLIMB BIO INC: 13G 3,070,000 shares, 5.25% of the class, 13G filed 2026-10-28, 0001193805-26-001408Timeline
    Accepted , ingested

Largest buys vs the previous quarter

SecurityShares changeApprox. value
CHEadded+152,000$76.8M
CELCadded+946,650$75.3M
UTHRadded+83,598$45.3M
ZTSnew+632,000$44.1M
BMRNadded+692,310$41.5M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
NUVLexited-17,248,450-$2.13B
VTRSreduced-9,268,170-$164M
LNTHexited-752,999-$83.5M
PFEexited-3,040,000-$73.2M
INDVexited-1,648,895-$67.7M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q3 2026

Share positions as resolved from 13F-HR 0001213900-26-120609, largest first. % of portfolio is the value over $6,465,822,053, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
RVMDREVOLUTION MEDICINES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 3,258,332 shares; 2025Q1: 3,317,332 shares; 2025Q2: 3,384,072 shares; 2025Q3: 3,650,342 shares; 2025Q4: 2,894,613 shares; 2026Q1: 2,297,000 shares; 2026Q2: 2,392,000 shares; 2026Q3: 2,124,000 shares 2,124,000$436M6.74%-268,000Timeline
CNCCENTENE CORP DELQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,671,921 shares; 2025Q1: 2,671,921 shares; 2025Q2: 3,185,370 shares; 2025Q3: 9,046,000 shares; 2025Q4: 6,447,998 shares; 2026Q1: 5,917,091 shares; 2026Q2: 4,901,000 shares; 2026Q3: 4,901,000 shares 4,901,000$304M4.71%0Timeline
UTHRUNITED THERAPEUTICS CORP DELQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 275,226 shares; 2025Q2: 540,626 shares; 2025Q3: 425,993 shares; 2025Q4: 425,993 shares; 2026Q1: 457,000 shares; 2026Q2: 457,000 shares; 2026Q3: 540,598 shares 540,598$293M4.53%+83,598Timeline
PRAXPRAXIS PRECISION MEDICINES IQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 619,931 shares; 2025Q2: 686,931 shares; 2025Q3: 840,851 shares; 2025Q4: 903,351 shares; 2026Q1: 963,351 shares; 2026Q2: 963,351 shares; 2026Q3: 963,351 shares 963,351$281M4.34%0Timeline
GMABGENMAB A/SQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 2,462,000 shares; 2026Q2: 6,865,000 shares; 2026Q3: 6,865,000 shares 6,865,000$245M3.79%0Timeline
VTRSVIATRIS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 23,996,036 shares; 2025Q1: 23,991,594 shares; 2025Q2: 24,023,907 shares; 2025Q3: 24,099,083 shares; 2025Q4: 20,206,170 shares; 2026Q1: 20,206,170 shares; 2026Q2: 20,206,170 shares; 2026Q3: 10,938,000 shares 10,938,000$194M3%-9,268,170Timeline
COGTCOGENT BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,631,000 shares; 2025Q1: 2,633,862 shares; 2025Q2: 2,640,215 shares; 2025Q3: 9,053,118 shares; 2025Q4: 9,043,903 shares; 2026Q1: 9,043,903 shares; 2026Q2: 5,006,104 shares; 2026Q3: 5,957,000 shares 5,957,000$191M2.95%+950,896Timeline
CELCCELCUITY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 733,530 shares; 2025Q4: 1,714,000 shares; 2026Q1: 1,714,000 shares; 2026Q2: 1,451,014 shares; 2026Q3: 2,397,664 shares 2,397,664$191M2.95%+946,650Timeline
LEGNLEGEND BIOTECH CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,551,718 shares; 2025Q1: 1,743,555 shares; 2025Q2: 2,962,338 shares; 2025Q3: 2,962,338 shares; 2025Q4: 5,932,000 shares; 2026Q1: 7,687,638 shares; 2026Q2: 8,137,638 shares; 2026Q3: 8,137,638 shares 8,137,638$162M2.5%0Timeline
VERAVERA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 1,050,000 shares; 2025Q2: 3,348,117 shares; 2025Q3: 3,641,157 shares; 2025Q4: 4,059,695 shares; 2026Q1: 3,722,100 shares; 2026Q2: 3,916,400 shares; 2026Q3: 4,338,778 shares 4,338,778$140M2.17%+422,378Timeline
TNGXTANGO THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 2,906,946 shares; 2026Q1: 4,146,813 shares; 2026Q2: 4,190,611 shares; 2026Q3: 5,180,000 shares 5,180,000$129M2%+989,389Timeline
BCRXBIOCRYST PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 8,144,442 shares; 2025Q1: 5,189,665 shares; 2025Q2: 4,692,000 shares; 2025Q3: 12,169,000 shares; 2025Q4: 14,341,000 shares; 2026Q1: 15,038,000 shares; 2026Q2: 15,096,403 shares; 2026Q3: 15,490,928 shares 15,490,928$129M2%+394,525Timeline
BKDBROOKDALE SR LIVING INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 15,612,264 shares; 2025Q1: 15,612,264 shares; 2025Q2: 15,362,264 shares; 2025Q3: 11,641,642 shares; 2025Q4: 11,637,032 shares; 2026Q1: 11,637,032 shares; 2026Q2: 11,637,032 shares; 2026Q3: 11,637,032 shares 11,637,032$126M1.95%0Timeline
BMRNBIOMARIN PHARMACEUTICAL INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 851,556 shares; 2026Q2: 1,332,836 shares; 2026Q3: 2,025,146 shares 2,025,146$122M1.88%+692,310Timeline
IONSIONIS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 1,979,669 shares; 2025Q4: 1,979,669 shares; 2026Q1: 1,979,669 shares; 2026Q2: 1,979,669 shares; 2026Q3: 2,660,669 shares 2,660,669$119M1.84%+681,000Timeline
LRMRLARIMAR THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 21,231,974 shares; 2025Q1: 21,231,974 shares; 2025Q2: 21,231,974 shares; 2025Q3: 30,606,974 shares; 2025Q4: 30,606,974 shares; 2026Q1: 35,606,974 shares; 2026Q2: 35,606,974 shares; 2026Q3: 35,606,974 shares 35,606,974$114M1.76%0Timeline
NAMSNEWAMSTERDAM PHARMA COMPANYQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 4,314,340 shares; 2025Q1: 4,103,957 shares; 2025Q2: 5,115,953 shares; 2025Q3: 4,266,693 shares; 2025Q4: 4,164,789 shares; 2026Q1: 4,264,789 shares; 2026Q2: 4,264,789 shares; 2026Q3: 4,254,314 shares 4,254,314$103M1.6%-10,475Timeline
MLYSMINERALYS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 3,958,000 shares; 2026Q3: 3,958,000 shares 3,958,000$99.5M1.54%0Timeline
BSXBOSTON SCIENTIFIC CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 31,312 shares; 2025Q4: 24,941 shares; 2026Q1: not reported; 2026Q2: 1,315,000 shares; 2026Q3: 2,135,440 shares 2,135,440$93.2M1.44%+820,440Timeline
CHECHEMED CORP NEWQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 4,664 shares; 2025Q4: 6,215 shares; 2026Q1: not reported; 2026Q2: 30,000 shares; 2026Q3: 182,000 shares 182,000$91.9M1.42%+152,000Timeline
INSPINSPIRE MED SYS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 140,000 shares; 2025Q3: 1,047,694 shares; 2025Q4: 1,505,872 shares; 2026Q1: 2,703,238 shares; 2026Q2: 1,296,862 shares; 2026Q3: 1,296,862 shares 1,296,862$90M1.39%0Timeline
BIOBIO RAD LABS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 151,644 shares; 2025Q1: 226,070 shares; 2025Q2: 226,070 shares; 2025Q3: 226,070 shares; 2025Q4: 226,070 shares; 2026Q1: 226,070 shares; 2026Q2: 226,070 shares; 2026Q3: 226,070 shares 226,070$85.4M1.32%0Timeline
PHVSPHARVARIS N VQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,017,464 shares; 2025Q1: 2,017,464 shares; 2025Q2: 2,017,464 shares; 2025Q3: 2,442,464 shares; 2025Q4: 3,126,042 shares; 2026Q1: 3,126,042 shares; 2026Q2: 3,376,042 shares; 2026Q3: 2,590,000 shares 2,590,000$82.2M1.27%-786,042Timeline
DNTHDIANTHUS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 1,019,813 shares; 2026Q2: 1,125,313 shares; 2026Q3: 914,000 shares 914,000$80.5M1.24%-211,313Timeline
IDYAIDEAYA BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,736,000 shares; 2025Q1: 3,267,551 shares; 2025Q2: 3,915,311 shares; 2025Q3: 2,153,043 shares; 2025Q4: 2,153,043 shares; 2026Q1: 1,530,008 shares; 2026Q2: 2,714,503 shares; 2026Q3: 2,003,000 shares 2,003,000$77M1.19%-711,503Timeline
SNDXSYNDAX PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 3,779,900 shares; 2026Q2: 3,779,900 shares; 2026Q3: 3,779,900 shares 3,779,900$71.1M1.1%0Timeline
SVRASAVARA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 7,964,000 shares; 2025Q1: 7,964,000 shares; 2025Q2: 7,964,000 shares; 2025Q3: 7,964,000 shares; 2025Q4: 13,569,000 shares; 2026Q1: 13,569,000 shares; 2026Q2: 13,569,000 shares; 2026Q3: 13,569,000 shares 13,569,000$70M1.08%0Timeline
CERTCERTARA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 2,022,616 shares; 2025Q2: 3,926,099 shares; 2025Q3: 6,739,537 shares; 2025Q4: 7,808,605 shares; 2026Q1: 7,808,605 shares; 2026Q2: 7,512,928 shares; 2026Q3: 7,512,928 shares 7,512,928$69.1M1.07%0Timeline
ACHCACADIA HEALTHCARE COMPANY INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 1,189,000 shares; 2025Q4: 4,520,000 shares; 2026Q1: 4,520,000 shares; 2026Q2: 4,520,000 shares; 2026Q3: 2,493,589 shares 2,493,589$68.6M1.06%-2,026,411Timeline
AHCOADAPTHEALTH CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 9,711,410 shares; 2025Q1: 9,711,410 shares; 2025Q2: 9,904,895 shares; 2025Q3: 11,477,730 shares; 2025Q4: 11,477,730 shares; 2026Q1: 11,477,730 shares; 2026Q2: 11,477,730 shares; 2026Q3: 11,477,730 shares 11,477,730$64.7M1%0Timeline
PBLSPARABILIS MEDICINES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 1,880,704 shares; 2026Q3: 1,880,704 shares 1,880,704$60.7M0.94%0Timeline
XENEXENON PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 542,020 shares; 2025Q3: 542,020 shares; 2025Q4: 542,020 shares; 2026Q1: 1,615,696 shares; 2026Q2: 1,615,696 shares; 2026Q3: 1,615,696 shares 1,615,696$60.1M0.93%0Timeline
ARWRARROWHEAD PHARMACEUTICALS INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 993,000 shares; 2025Q4: 1,832,946 shares; 2026Q1: 1,573,297 shares; 2026Q2: 1,389,055 shares; 2026Q3: 843,063 shares 843,063$55.2M0.85%-545,992Timeline
NVSTENVISTA HOLDINGS CORPORATIONQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,018,415 shares; 2025Q1: 2,024,943 shares; 2025Q2: 2,215,845 shares; 2025Q3: 2,294,036 shares; 2025Q4: 2,280,498 shares; 2026Q1: 2,210,100 shares; 2026Q2: 2,210,100 shares; 2026Q3: 2,210,100 shares 2,210,100$51.9M0.8%0Timeline
STOKSTOKE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 1,823,500 shares; 2026Q1: 1,823,500 shares; 2026Q2: 1,823,500 shares; 2026Q3: 1,823,500 shares 1,823,500$47.4M0.73%0Timeline
ZTSZOETIS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 1,310 shares; 2025Q3: 8,554 shares; 2025Q4: 5,698 shares; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 632,000 shares 632,000$44.1M0.68%newTimeline
IRONDISC MEDICINE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 600,515 shares; 2025Q1: 782,333 shares; 2025Q2: 919,403 shares; 2025Q3: 919,403 shares; 2025Q4: 511,163 shares; 2026Q1: 657,000 shares; 2026Q2: 657,000 shares; 2026Q3: 657,000 shares 657,000$43M0.67%0Timeline
BBNXBETA BIONICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 1,016,000 shares; 2025Q2: 1,168,415 shares; 2025Q3: 1,168,415 shares; 2025Q4: 938,308 shares; 2026Q1: 1,324,000 shares; 2026Q2: 1,324,000 shares; 2026Q3: 1,903,710 shares 1,903,710$36.1M0.56%+579,710Timeline
GPCRSTRUCTURE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 373,407 shares; 2025Q1: 373,407 shares; 2025Q2: 373,407 shares; 2025Q3: 373,407 shares; 2025Q4: 767,993 shares; 2026Q1: 767,993 shares; 2026Q2: 1,086,000 shares; 2026Q3: 1,086,000 shares 1,086,000$34M0.53%0Timeline
SPRYARS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 10,514,657 shares; 2025Q1: 10,514,657 shares; 2025Q2: 9,724,508 shares; 2025Q3: 7,503,812 shares; 2025Q4: 7,503,812 shares; 2026Q1: 7,503,812 shares; 2026Q2: 7,503,812 shares; 2026Q3: 7,503,812 shares 7,503,812$32.3M0.5%0Timeline
BLTEBELITE BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 233,813 shares; 2026Q1: 304,013 shares; 2026Q2: 357,199 shares; 2026Q3: 190,000 shares 190,000$32.3M0.5%-167,199Timeline
COOCOOPER COS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 6,328 shares; 2025Q3: 43,110 shares; 2025Q4: 7,786 shares; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 557,000 shares 557,000$31.5M0.49%newTimeline
BLSMBLOSSOMHILL THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 1,446,000 shares 1,446,000$27M0.42%newTimeline
ODTXODYSSEY THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 1,046,139 shares; 2026Q3: 1,046,139 shares 1,046,139$23.2M0.36%0Timeline
TNDMTANDEM DIABETES CARE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 12,195 shares; 2025Q4: 26,090 shares; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 1,390,909 shares 1,390,909$22.7M0.35%newTimeline
STLNSTARLING ONCOLOGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 3,360,052 shares; 2025Q1: 3,360,052 shares; 2025Q2: 3,360,052 shares; 2025Q3: 3,360,052 shares; 2025Q4: 3,360,052 shares; 2026Q1: 3,360,052 shares; 2026Q2: 3,360,052 shares; 2026Q3: 3,360,052 shares 3,360,052$21.2M0.33%0Timeline
AVLNAVALYN PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 731,000 shares; 2026Q3: 731,000 shares 731,000$20.8M0.32%0Timeline
ALMRALAMAR BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 600,000 shares; 2026Q3: 600,000 shares 600,000$20.4M0.32%0Timeline
TYRATYRA BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 549,000 shares; 2026Q2: 1,017,000 shares; 2026Q3: 732,392 shares 732,392$16M0.25%-284,608Timeline
FHTXFOGHORN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 3,255,514 shares; 2025Q1: 3,255,514 shares; 2025Q2: 3,255,514 shares; 2025Q3: 3,255,514 shares; 2025Q4: 3,649,211 shares; 2026Q1: 4,394,367 shares; 2026Q2: 4,394,367 shares; 2026Q3: 4,394,367 shares 4,394,367$15.7M0.24%0Timeline
VOGXVOGENX INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 635,707 shares 635,707$14.5M0.22%newTimeline
EMBCEMBECTA CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 3,270,535 shares; 2025Q1: 2,720,535 shares; 2025Q2: 2,749,712 shares; 2025Q3: 2,620,421 shares; 2025Q4: 2,752,031 shares; 2026Q1: 2,534,961 shares; 2026Q2: 2,534,961 shares; 2026Q3: 2,534,961 shares 2,534,961$14.3M0.22%0Timeline
BBOTBRIDGEBIO ONCOLOGY THERAPEUTQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 4,885,446 shares; 2025Q4: 4,885,446 shares; 2026Q1: 4,885,446 shares; 2026Q2: 4,885,446 shares; 2026Q3: 3,138,167 shares 3,138,167$12.9M0.2%-1,747,279Timeline
DRUGBRIGHT MINDS BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 283,000 shares; 2026Q2: 283,000 shares; 2026Q3: 236,295 shares 236,295$11.8M0.18%-46,705Timeline
MNPRMONOPAR THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 159,765 shares; 2025Q4: 170,558 shares; 2026Q1: 323,745 shares; 2026Q2: 323,745 shares; 2026Q3: 137,591 shares 137,591$11M0.17%-186,154Timeline
ALHCALIGNMENT HEALTHCARE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 7,304,302 shares; 2025Q1: 4,567,473 shares; 2025Q2: 342,558 shares; 2025Q3: 102,942 shares; 2025Q4: 164,345 shares; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 1,172,418 shares 1,172,418$9.57M0.15%newTimeline
ADAGADAGENE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 2,666,666 shares; 2026Q3: 2,666,666 shares 2,666,666$8.53M0.13%0Timeline
COAGHEMAB THERAPEUTICS HLDGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 275,000 shares; 2026Q3: 275,000 shares 275,000$8.48M0.13%0Timeline
ETRAELECTRA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 700,000 shares 700,000$7.88M0.12%newTimeline
ANNXANNEXON INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 583,913 shares; 2025Q1: 583,913 shares; 2025Q2: 583,913 shares; 2025Q3: 583,913 shares; 2025Q4: 583,913 shares; 2026Q1: 583,913 shares; 2026Q2: 583,913 shares; 2026Q3: 583,913 shares 583,913$2.47M0.04%0Timeline
ALECALECTOR INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,066,962 shares; 2025Q1: 1,055,192 shares; 2025Q2: 1,055,192 shares; 2025Q3: 1,055,192 shares; 2025Q4: 1,055,192 shares; 2026Q1: 1,055,192 shares; 2026Q2: 1,055,192 shares; 2026Q3: 1,055,192 shares 1,055,192$1.95M0.03%0Timeline
EWEDWARDS LIFESCIENCES CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 6,349 shares; 2025Q4: 13,702 shares; 2026Q1: 13,702 shares; 2026Q2: 13,702 shares; 2026Q3: 13,702 shares 13,702$1.18M0.02%0Timeline
NAMSWNEWAMSTERDAM PHARMA COMPANYQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 92,787 shares; 2025Q1: 92,787 shares; 2025Q2: 92,787 shares; 2025Q3: 92,787 shares; 2025Q4: 92,787 shares; 2026Q1: 92,787 shares; 2026Q2: 92,787 shares; 2026Q3: 92,787 shares 92,787$1.17M0.02%0Timeline
MIRMMIRUM PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 6,027 shares; 2026Q3: 6,027 shares 6,027$515K0.01%0Timeline
HUMHUMANA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 917 shares; 2025Q1: 917 shares; 2025Q2: 917 shares; 2025Q3: 917 shares; 2025Q4: 917 shares; 2026Q1: 917 shares; 2026Q2: 917 shares; 2026Q3: 917 shares 917$350K0.01%0Timeline
STLNWSTARLING ONCOLOGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,250,000 shares; 2025Q1: 1,250,000 shares; 2025Q2: 1,250,000 shares; 2025Q3: 1,250,000 shares; 2025Q4: 1,250,000 shares; 2026Q1: 1,250,000 shares; 2026Q2: 1,250,000 shares; 2026Q3: 1,250,000 shares 1,250,000$61K<0.01%0Timeline
PMVPPMV PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 8,790 shares; 2025Q3: 8,790 shares; 2025Q4: 8,790 shares; 2026Q1: 8,790 shares; 2026Q2: 8,790 shares; 2026Q3: 8,790 shares 8,790$14.7K<0.01%0Timeline

Principal amounts

Notes and convertibles filed as a face amount (PRN). A face amount is never added to a share count (H6).

SecurityTypeAmountValueChange
BROOKDALE SR LIVING INCBROOKDALE SR LIVING INC NOTE 3.500%10/1principal306,885,000$426M0
REVOLUTION MEDICINES INCREVOLUTION MEDICINES INC NOTE 0.500% 5/0principal200,000,000$258M0
ARROWHEAD PHARMACEUTICALS INARROWHEAD PHARMACEUTICALS IN Convertibleprincipal200,000,000$206M0
CELCUITY INCCELCUITY INC Convertibleprincipal100,000,000$96.5M0
TEMPUS AI INCTEMPUS AI INC NOTE 0.750% 7/1principal70,000,000$88.2Mnew
ZENAS BIOPHARMA INCZENAS BIOPHARMA INC NOTE 2.500% 4/0principal67,200,000$85.7M0
IONIS PHARMACEUTICALS INCIONIS PHARMACEUTICALS INC NOTE 1.750% 6/1principal60,000,000$66M0
ALIGNMENT HEALTHCARE INCALIGNMENT HEALTHCARE INC NOTE 4.250%11/1principal61,000,000$61.1M0
LIVANOVA PLCLIVANOVA PLC NOTE 2.500% 3/1principal34,280,000$44M0
NEOGENOMICS INCNEOGENOMICS INC NOTE 0.250% 1/1principal13,040,000$12.3M0

Sold out in Q3 2026

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
NUVLNUVALENT INC17,248,450$2.13Bshares
LNTHLANTHEUS HLDGS INC752,999$83.5Mshares
PFEPFIZER INC3,040,000$73.2Mshares
INDVINDIVIOR PHARMACEUTICALS INC1,648,895$67.7Mshares
CDNACAREDX INC1,997,618$56.9Mshares
SIONSIONNA THERAPEUTICS INC680,916$30Mshares
IMMUNOCORE HLDGS PLCIMMUNOCORE HLDGS PLC30,000,000$27.1Mprincipal
ALNYALNYLAM PHARMACEUTICALS INC67,935$20.5Mshares
KYTXKYVERNA THERAPEUTICS INC2,000,000$17.8Mshares
SGPSPYGLASS PHARMA INC550,000$12.2Mshares
MOBIMOBIA MED INC670,752$8.99Mshares
VCYTVERACYTE INC101,000$5.93Mshares
SRZNWSURROZEN INC166,666$2.75Kshares

How Q3 2026 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001213900-26-120609 base2026-11-16